Penumbra (PEN) Cost of Revenue (2014 - 2026)
Penumbra's (PEN) quarterly Cost of Revenue came in at $125.1 million in Q2 2026, up 8.37% year-over-year from $115.4 million in Q2 2025, and up 3.09% quarter-over-quarter from $121.3 million in Q1 2026.
Analysis
Penumbra (PEN) Cost of Revenue (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Cost of Revenue for 13 consecutive years, with $125.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cost of Revenue rose 8.37% year-over-year to $125.1 million in Q2 2026; TTM through Jun 2026 was $484.0 million, a 12.75% increase from a year earlier, with the FY2025 full-year figure at $461.2 million, up 4.92% from the prior year.
- Cost of Revenue was $125.1 million for Q2 2026 at Penumbra, up from $121.3 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $136.6 million in Q2 2024 and troughed at $74.3 million in Q2 2022.
- A 5-year average of $102.0 million and a median of $99.2 million in 2023 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue soared 44.31% in 2024 and fell 15.47% in 2025, its largest moves.
- Over 5 years, Cost of Revenue stood at $82.8 million in 2022, then gained by 18.0% to $97.7 million in 2023, then gained by 7.28% to $104.8 million in 2024, then climbed by 17.62% to $123.3 million in 2025, then grew by 1.5% to $125.1 million in 2026.
- The last three Cost of Revenue figures came in at $125.1 million (Q2 2026), $121.3 million (Q1 2026), and $123.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 931.90 Mn |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn | 3.42 Bn |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn | 2.09 Bn |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn | 1.59 Bn |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn | 392.40 Mn |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | 18.00 Mn |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn | 478.40 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Penumbra | 12.58 Bn | 11.92 Bn | 264.94 Mn | 125.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.10 Mn |
| Mar 31, 2026 | 121.35 Mn |
| Dec 31, 2025 | 123.26 Mn |
| Sep 30, 2025 | 114.27 Mn |
| Jun 30, 2025 | 115.45 Mn |
| Mar 31, 2025 | 108.26 Mn |
| Dec 31, 2024 | 104.80 Mn |
| Sep 30, 2024 | 100.73 Mn |
| Jun 30, 2024 | 136.57 Mn |
| Mar 31, 2024 | 97.52 Mn |
| Dec 31, 2023 | 97.69 Mn |
| Sep 30, 2023 | 93.23 Mn |
| Jun 30, 2023 | 94.64 Mn |
| Mar 31, 2023 | 90.33 Mn |
| Dec 31, 2022 | 82.79 Mn |
| Sep 30, 2022 | 78.35 Mn |
| Jun 30, 2022 | 74.31 Mn |
| Mar 31, 2022 | 76.48 Mn |
| Dec 31, 2021 | 78.56 Mn |
| Sep 30, 2021 | 70.21 Mn |